TrendFlares logo

Cerevel Therapeutics Holdings, Inc. (CERE)

$44.96 0.74% $0.33 Healthcare

Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-concept trial in patients with drug-resistant focal onset seizures in epilepsy or focal epilepsy, as well as in phase 1 trial to treat acute anxiety. The company's products also comprise Tavapadon, a selective dopamine D1/D5 partial agonist that is in phase 3 clinical trial for the treatment of early- and late-stage Parkinson's disease; CVL-871, a selective dopamine D1/D5 partial agonist, which is in Phase 2a clinical trial to treat dementia-related apathy; CVL-936, a selective dopamine D3-preferring antagonist, which is in Phase I clinical trial for the treatment of substance use disorder; CVL-354, a selective kappa-opioid receptor antagonist to treat major depressive disorder and substance use disorder; and CVL-047, selective PDE4 inhibitor for the treatment of major depressive disorder and substance use disorder. It is also involved in the development of an M4 agonist program for the treatment of psychosis and related indications; and an LRRK2 inhibitor program to address disease progression in Parkinson's. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.

$8.19B

Dr. N. Anthony Coles Jr., M.P.H.

285.00

Cambridge, MA

Jul 30, 2020

-16.47

$-2.73

3.81

10.22

-5,584.14%

-17.73

0.17

14.47

993.39

10.12

-40.85%

-98.94%

Uptrend

Similar stocks (18)

Revolution Medicines, Inc.

RVMD

$46.18 4.81%
Uptrend

Nuvalent, Inc.

NUVL

$103.25 0.60%
Uptrend

Blueprint Medicines Corporation

BPMC

$90.94 1.80%
Downtrend

Avidity Biosciences, Inc.

RNA

$45.65 2.29%
Uptrend

Apellis Pharmaceuticals, Inc.

APLS

$36.73 3.09%
Downtrend

SpringWorks Therapeutics, Inc.

SWTX

$35.35 -0.65%
Downtrend

Structure Therapeutics Inc.

GPCR

$38.75 1.28%
Downtrend

Day One Biopharmaceuticals, Inc.

DAWN

$14.32 3.84%
Downtrend

Travere Therapeutics, Inc.

TVTX

$15.06 4.95%
Uptrend

Cullinan Oncology, Inc.

CGEM

$17.94 4.12%
Downtrend

IGM Biosciences, Inc.

IGMS

$17.23 3.48%
Uptrend

Stoke Therapeutics, Inc.

STOK

$15.14 -0.53%
Uptrend

Terns Pharmaceuticals, Inc.

TERN

$10.04 -1.67%
Uptrend

Monte Rosa Therapeutics, Inc.

GLUE

$6.25 5.04%
Neutral

Design Therapeutics, Inc.

DSGN

$5.86 3.90%
Uptrend

Ventyx Biosciences, Inc.

VTYX

$2.37 3.49%
Downtrend

Werewolf Therapeutics, Inc.

HOWL

$2.40 8.11%
Downtrend

Ikena Oncology, Inc.

IKNA

$1.71 3.01%
Neutral

ETF Exposure (24)

Vanguard Small Cap Growth Index Fund

VBK

0.13%

$267.41 1.83%
Uptrend

Schwab U.S. Small-Cap ETF

SCHA

0.0994471776%

$51.96 1.90%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0.06%

$136.02 0.03%
Uptrend

Vanguard Extended Market Index Fund

VXF

0.06%

$182.92 2.00%
Uptrend

Vanguard Small Cap Index Fund

NAESX

0.05%

$111.91 0.05%
Uptrend

Vanguard Small Cap Index Fund

VB

0.05%

$237.72 1.69%
Uptrend

Vanguard Health Care Index Fund

VHT

0.05%

$286.45 0.57%
Uptrend

Vanguard Small-Cap Index Fund Institutional Shares

VSCIX

0.05%

$111.94 0.05%
Uptrend

Vanguard ESG U.S. Stock ETF

ESGV

0.01%

$101.38 1.88%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0.01%

$96.13 -0.25%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0.01%

$96.11 -0.25%
Uptrend

Vanguard Russell 1000 Index Fund

VONE

0.01%

$258.96 1.62%
Uptrend

Vanguard Russell 1000 Growth Index Fund

VONG

0.01%

$96.11 2.39%
Uptrend

Vanguard Tax-Managed Capital Appreciation Fund Institutional Shares

VTCIX

0.01%

$143.65 -0.25%
Uptrend

Vanguard Tax-Managed Capital Appreciation Fund

VTCLX

0.01%

$289.12 -0.25%
Uptrend

Vanguard Russell 3000 Index Fund

VTHR

0.01%

$253.06 1.86%
Uptrend

Schwab U.S. Broad Market ETF

SCHB

0.0065233749%

$66.24 1.72%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.43 -0.28%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.42 -0.28%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.42 -0.26%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$134.99 -0.24%
Uptrend

Vanguard Total World Stock Index Fund

VT

0%

$118.76 1.77%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$282.05 1.69%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$134.97 -0.24%
Uptrend